Jones, Cheshire
Clifford Jones, Cheshire GB
Patent application number | Description | Published |
---|---|---|
20080280906 | Imidazolyl-Pyrimidine Compounds for Use in the Treatment of Proliferative Disorders - Compounds of formula (I): | 11-13-2008 |
20090054409 | IMIDAZO [1,2-A] PYRIDINE HAVING ANTI-CELL-PROLIFERATION ACTIVITY - Compounds of formula (I): | 02-26-2009 |
20090099160 | 4-(4-(Imidazol-4-Yl) Pyrimidin-2-Ylamino) Benzamides as CDK Inhibitors - Compounds of the formula (I): | 04-16-2009 |
20090233928 | IMIDAZOLO-5-YL-2-ANILO-PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CELL PROLIFERATION - Compounds of the formula (I): | 09-17-2009 |
20090275567 | 2-HETEROCYCLOAMINO-4-IMIDAZOLYLPYRIMIDINES AS AGENTS FOR THE INHIBITION OF CELL PROLIFERATION - Compounds of formula (I): | 11-05-2009 |
20100240686 | CHEMICAL COMPOUNDS - Compounds of formula (I): | 09-23-2010 |
Clifford David Jones, Cheshire GB
Patent application number | Description | Published |
---|---|---|
20080207636 | Compounds Effecting Glucokinase - The invention relates to the use of a compound of Formula (I) or a salt, solvate or prodrug thereof, wherein R | 08-28-2008 |
20110118238 | 2-ANILINOPURIN-8-ONES AS INHIBITORS OF TTK/MPS1 FOR THE TREATMENT OF PROLIFERATIVE DISORDERS - This invention relates to chemical compounds of the formula (I), or a pharmaceutically acceptable salt thereof, which possess inhibitory activity against the spindle checkpoint kinase: Tyrosine Threonine Kinase (TTK)/monopolar spindle 1 (Mps1) and are accordingly useful for their anti-cancer effect in a warm-blooded animal such as man. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them, and to their use in the manufacture of a medicament for the treatment of conditions mediated by TTK/Mps1, for use either alone or in combination with other anti-pro liferative agents. | 05-19-2011 |
20110166139 | PYRIDINE COMPOUNDS - The present invention relates to compounds that inhibit of focal adhesion kinase function, processes for their preparation, pharmaceutical compositions containing them as the active ingredient, to their use as medicaments and to their use in the manufacture of medicaments for use in the treatment in warm-blooded animals such as humans of diseases such as cancer. | 07-07-2011 |
Duncan Jones, Cheshire GB
Patent application number | Description | Published |
---|---|---|
20110135974 | System and Method for Monitoring Electrolyte Levels in a Battery - A measuring device is used in conjunction with a programmable controller for monitoring electrolyte levels in the battery. According to one implementation, the measuring device is located in a battery and is configured to detect when the electrolyte level in the battery falls below a particular level. The controller is in electrical communication with the electrolyte detection device. The controller is configured to: (i) receive a signal from the electrolyte level detection device indicating when the electrolyte level in the battery has fallen below the particular level; (ii) introduce a wait-period after the signal is received; and (iii) enable an indicator to indicate that the electrolyte level in the battery should be refilled when the wait-period expires. | 06-09-2011 |
20130229187 | System and Method for Monitoring Electrolyte Levels in a Battery - A measuring device is used in conjunction with a programmable controller for monitoring electrolyte levels in the battery. According to one implementation, the measuring device is located in a battery and is configured to detect when the electrolyte level in the battery falls below a particular level. The controller is in electrical communication with the electrolyte detection device. The controller is configured to: (i) receive a signal from the electrolyte level detection device indicating when the electrolyte level in the battery has fallen below the particular level; (ii) introduce a wait-period after the signal is received; and (iii) enable an indicator to indicate that the electrolyte level in the battery should be refilled when the wait-period expires. | 09-05-2013 |
Ivor Wynn Jones, Cheshire GB
Patent application number | Description | Published |
---|---|---|
20120017963 | THERMOELECTRIC MODULE WITH INSULATED SUBSTRATE - In a thermoelectric module comprising a series of p and n type semiconductors con | 01-26-2012 |
20120024332 | THERMOELECTRIC MATERIAL COATED WITH A PROTECTIVE LAYER - A thermoelectric material in a shape for forming part of a thermoelectric module, the thermoelectric material is coated with a protective layer to prevent degradation by humidity, oxygen, chemicals or thermal stress. | 02-02-2012 |
Peter Thomas Jones, Cheshire GB
Patent application number | Description | Published |
---|---|---|
20130340033 | APPARATUS, METHODS AND MEDIA FOR LOCATION BASED DATA ACCESS POLICIES - A method of administering an application management policy is provided. The method includes determining, in response to a request for access to a service, whether the first device is known. The service is provided by an application running on the server. The method also includes determining whether the first device is capable of providing location information. The method further includes, when it is determined that the first device is incapable of providing the location information, determining whether the first device is in communication with a second device capable of providing second location information. The first and second devices are in close proximity that the second location information can be used as a proxy for the first location information. The method also includes determining the physical location of the first device using the second location information. The method further includes setting the policy based on the physical location of the first device. | 12-19-2013 |
Stuart Donald Jones, Cheshire GB
Patent application number | Description | Published |
---|---|---|
20110046093 | PYRIMIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS - The present invention relates to a compound of formula (VII)I, or a pharmaceutically acceptable salt or ester thereof, wherein: X is NR | 02-24-2011 |
20140066436 | PYRIMIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS - The present invention relates to a compound of formula (VII)I, or pharmaceutically acceptable salt or ester thereof, wherein: X is NR | 03-06-2014 |